论文部分内容阅读
任汉云:医学博士,教授,主任医师,博士生导师。现任北京大学第一医院血液科主任、中华医学会血液学会委员、中华医学会北京血液学会副主任委员、中华骨髓库专家委员会委员、中华医学会血液学会造血干细胞临床应用学组成员。1987年就读于北京医科大学研究生院,开始骨髓移植的临床和基础研究工作。1992年公派去日本自治医科大学留学,获博士学位。1994年回国后先后承担国家自然科学基金4项、高校“211”工程科研基金项目和教育部科研基金项目各1项。先后在国内外学术期刊和会议上发表论文40余篇,参与编写著作5部。擅长白血病、淋巴瘤和多发性骨髓瘤的化疗,在造血干细胞移植包括骨髓移植、周围血干细胞移植和脐血移植方面有很深的造诣,是北京市和国家血液学重点学科主要负责人之一,熟练掌握造血干细胞移植相关技术。近年来主持完成350余例各类造血干细胞移植手术,患者康复后长期生存率在75%以上。成功实施了国内首例成人脐血移植,还成功实施了国内首例应用半相合骨髓移植治疗遗传性肾上腺脑白质营养不良,在国内血液学界有较大影响。为北京大学血液病学领域的主要学科带头人之一,2001年被北京大学推荐为“长江学者”候选人。
Ren Hanyun: MD, Professor, chief physician, doctoral tutor. The incumbent Peking University First Hospital hematology director, the Chinese Medical Association hematology society, the Chinese Medical Association Beijing hematology society vice chairman, China bone marrow pool of experts committee, the Chinese Medical Association hematology hematopoietic stem cell clinical research group. In 1987, he studied at the Graduate School of Beijing Medical University and started clinical and basic research on bone marrow transplantation. In 1992, he was sent to go to Japan Autonomous Medical University to study, received a doctor's degree. After returning to China in 1994, he has undertaken 4 projects of National Natural Science Foundation, 211 “Project Research Fund for Universities and 1 Scientific Research Fund of the Ministry of Education respectively. He has published more than 40 papers in academic journals and conferences at home and abroad, and participated in the preparation of 5 books. He is good at chemotherapy of leukemia, lymphoma and multiple myeloma and has deep knowledge in hematopoietic stem cell transplantation including bone marrow transplantation, peripheral blood stem cell transplantation and umbilical cord blood transplantation. He is one of the chief leaders of Beijing and National Hematology Key Disciplines , Master the relevant technology of hematopoietic stem cell transplantation. In recent years presided over the completion of more than 350 cases of various types of hematopoietic stem cell transplantation, long-term survival of patients after recovery in more than 75%. The successful implementation of the first domestic adult cord blood transplantation, but also the successful implementation of the first application of semi-hemisertial transplantation in the treatment of hereditary adrenoleukodystrophy, hematology in the country have a greater impact. Peking University Department of Hematology, one of the major academic leaders, Peking University in 2001 was recommended as ”Cheung Kong Scholar" candidate.